Pulmonary arterial hypertension Trials in Baltimore, United States
Conditions / Pulmonary arterial hypertension / Baltimore, United States
Clinical trials for Pulmonary arterial hypertension investigate a range of treatment strategies and patient populations.
49 total trials for this combination
Showing top 10 of 49 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01106014 | Selexipag (ACT-293987) in Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |
| NCT01431326 | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | COMPLETED | — |
| NCT04278404 | Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | RECRUITING | — |
| NCT01560624 | Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy | COMPLETED | PHASE3 |
| NCT01112306 | ACT-293987 in Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |
| NCT04811092 | Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) | TERMINATED | — |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT04796337 | A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01027949 | An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |